Srs Pharmaceuticals Private Limited, a active private limited company, was established on 27 March 2001 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH2001PTC131384. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.
It upholds a compliant status. Employing 87 professional, Its leadership includes Pooja Ketan Deshpande (Director), Suchet Shyamsunder Rastogi (Director), Anuradha Ganesh Naik (Additional Director). Past directors included Mahika Suchet Rastogi, Kajol Gaurav Somani, Aman Singh Siwach. It holds ₹18.00 Cr open charges and ₹12.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 504 Marathon Max Bldg No.2, Mulund-Goregoan Link, L.B.S Marg, Mulund West Mumbai Mh 400080, In, Mumbai, Maharashtra, 400080.
U24239MH2001PTC131384
131384
27 March 2001
₹5.00 Cr
₹5.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Srs Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pooja Ketan Deshpande | Director | 10 Jun 2024 | Current |
| Suchet Shyamsunder Rastogi | Director | 27 Mar 2001 | Current |
| Anuradha Ganesh Naik | Additional Director | 30 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Oct 2016 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 01 Feb 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Srs Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 69.94% decrease. The company also saw a substantial fall in profitability, with a 95.3% decrease in profit. The company's net worth moved up by a moderate rise of 4.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Srs Pharmaceuticals had a promoter holding of 99.00% and a public holding of 1.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹180,000,000.00
₹120,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Sep 2024 | Hdfc Bank Limited | ₹10.00 Cr | Open |
| 15 Dec 2009 | Standard Chartered Bank | ₹8.00 Cr | Open |
| 16 Sep 2015 | Standard Chartered Bank | ₹1.50 M | Satisfied |
| 06 Jan 2005 | Standard Chartered Bank | ₹11.25 Cr | Satisfied |
| 24 May 2002 | Development Credit Bank Ltd. | ₹6.00 M | Satisfied |
Explore comprehensive loan charge details -
Srs Pharmaceuticals has a workforce of 87 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Srs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srs Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 16 Sep 2015 via Charge ID 10591262 with Standard Chartered Bank was fully satisfied on 12 Sep 2025. was documented.
The activity A charge registered on 06 Jan 2005 via Charge ID 90149601 with Standard Chartered Bank was fully satisfied on 12 Sep 2025. was completed.
The activity Anuradha Ganesh Naik was appointed as a Additional Director was appointed as a Additional Director on 30 Apr 2025 & has been associated with this company since 7 months 5 days . was completed.
The activity Srs Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100984066 was registered on 03 Sep 2024. was completed.
Komal Dilip Jain was appointed as a Company Secretary was appointed as a Company Secretary on 08 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
The CIN of Srs Pharmaceuticals Private Limited is U24239MH2001PTC131384.
Srs Pharmaceuticals Private Limited is headquartered at 504 Marathon Max Bldg No.2, Mulund-Goregoan Link, L.B.S Marg, Mulund West Mumbai Mh 400080, In, Mumbai, Maharashtra, 400080.
Srs Pharmaceuticals Private Limited was incorporated on 27 March 2001.
The current directors of Srs Pharmaceuticals Private Limited are
The primary industry of Srs Pharmaceuticals Private Limited is Manufacturing.
Srs Pharmaceuticals Private Limited is unlisted.
The authorized capital of Srs Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.
The compliance status of Srs Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX